Peptide questions · 5-Amino-1MQ
How long does 5-Amino-1MQ take to work?
Reviewed Evidence: EmergingPublished by PepVault
The library’s research notes on 5-Amino-1MQ start on day 1, with “Quiet compound, slow signal” (animal study), and run to day 168.
The library holds no onset-and-peak timeline for 5-Amino-1MQ, so this page reads its notes by day.
5-Amino-1MQ week by week
The library places three of its research notes on 5-Amino-1MQ on the days they cover, from day 1 to day 168: 3 on animal studies.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–28 (weeks 1–4) | Quiet compound, slow signal | Animal study |
| Days 28–84 (weeks 4–12) | Recomp in a deficit | Animal study |
| Days 84–168 (weeks 12–24) | Cycle decision point | Animal study |

Model. Individual results vary.
Why 5-Amino-1MQ takes that long
The library states no half-life with a number for 5-Amino-1MQ (it says: “Unknown”), so this page can’t work out a build-up; the timing rests on the notes above.
5-Amino-1MQ against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds; it holds none for 5-Amino-1MQ, so its timing rests on the notes above.
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does 5-Amino-1MQ take to work?
The library’s research notes on 5-Amino-1MQ start on day 1, with “Quiet compound, slow signal” (animal study), and run to day 168.
What does the library say about the first days on 5-Amino-1MQ?
Its first note on 5-Amino-1MQ, for days 1–28 (weeks 1–4), is “Quiet compound, slow signal”, resting on animal studies.